According to survival analysis and differential expression of the lncRNA targets, only GABPB1-AS1 significantly decreased the survival probability of patients with GBM (P = 0.05; Fig. 9E) and it was upregulated significantly in the GBM samples (|log2FC| < 1; P < 0.01; Fig. 9F). The gene discussed is GABPB1; the disease is glioblastoma.